MiMedx Group Stock Price and Value Analysis

Should you buy MiMedx Group stock? (Other OTC:MDXG). Let's see how it does in our automated value investing analysis system.

  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.
  • This company pays no dividend.

Inside the MDXG Numbers

MDXG Price
(MiMedx Group stock price per share)
[?] PE Ratio versus Sector 2% higher than other Healthcare stocks
[?] PE Ratio versus Industry 48% higher than other Medical Devices stocks
[?] Free Cash Flow Jitter 140%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,678,781 shares shorted. With 96,853,683 shares available for purchase and an average trading volume over the past 10 trading days of 847,380, it would take at least 4.341 days for all of the short holders to cover their shorts.

Is MiMedx Group Stock on Sale?

Based on our analysis, we believe that you should not buy MiMedx Group right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MDXG Stock?

Does MiMedx Group have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.